PRI Bio Selected to Provide NBAF Bio-Hazardous Waste Decontamination System

PRI-Bio Selected to Provide World’s Largest Bio-Hazardous Waste Decontamination System for U.S. Department of Homeland Security, National Bio and Agro-Defense Facility (NBAF)

PRI Bio, a wholly owned division of Progressive Recovery, Inc., has been selected by McCarthy/Mortenson and DHS to provide multiple bio-hazardous waste decontamination systems for the $1.25 billion National Bio and Agro-Defense Facility, a DHS Science and Technology Directorate project located in Manhattan, Kansas. This will be the world’s largest bio-hazardous waste decontamination system.

Under the contract, PRI-Bio will be designing, fabricating and installing numerous effluent decontamination systems capable of sterilizing several times the capacity of both the aging Plum Island Animal Disease Center, the facility NBAF is replacing; and of PRI’s system at USAMRIID, currently the world’s largest effluent sterilization system.   PRI-Bio will also be providing several state-of-art, 3rd Generation Tissue Autoclaves to sterilize solid biological waste streams.

The NBAF campus will include over 700,000 square feet of facility space, including the 574,000 square feet main lab building, which houses biosafety level (BSL) 2, 3 and 4 shared research space to be constructed on the 48-acre site. The facility will have advanced research, diagnostic testing and validation, countermeasure development (i.e., vaccines and anti-viral therapies) and diagnostic training for high-consequence livestock diseases. It will also provide the necessary infrastructure to improve understanding and preparedness for potential bioterrorism employing foreign animal disease and zoonotic disease pathogens that may be accidentally or intentionally introduced in the United States and will develop capabilities to improve protection against such threats to our food supply, our nation’s agriculture economy, and public health.

“The NBAF project highlights our commitment to support the U.S. Government in bio-hazardous waste management”, said Craig Morley, PRI-Bio’s Head of Commercial Operations. “Our systems ensure effective treatment and sterilization of bio-hazardous waste, protecting the health and welfare of researchers and other facility staff, as well as the general public and the environment.”